Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lynn

Showing results (221-230 of 604) with videos related to

Pageof 61
Sort By:
Drug and Alcohol Dependence|May 30, 2024
Longitudinal trajectories in recovery capital and associations with substance use among adult drug treatment court clientsKyler S Knapp, Jessica A Kulak, D Lynn Homish, et al.
Clinical and Translational Science|March 21, 2024
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteersD Lynn Kirkpatrick, Cari Evans, Linda A Pestano, et al.
Annals of Surgery|April 26, 2007
Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experienceSarah K Thompson, Amanda V Hayman, William H Ludlam, et al.
Psycho-Oncology|November 11, 2014
Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversyHeather Orom, Willie Underwood, D Lynn Homish, et al.
Psychological Services|February 15, 2019
Is deployment status the critical determinant of psychosocial problems among reserve/guard soldiers?Rachel A Hoopsick, D Lynn Homish, R Lorraine Collins, et al.
Plos One|November 6, 2009
Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancerChristina L Roland, Kristi D Lynn, Jason E Toombs, et al.
Molecular Cancer Therapeutics|January 19, 2008
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alphaMei Y Koh, Taly Spivak-Kroizman, Sara Venturini, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|January 12, 2008
Patterns and predictors of early hospital readmission in patients with congestive heart failureMarco Hallerbach, Amanda Francoeur, Sherry C Pomerantz, et al.
BMC Cancer|August 3, 2010
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancerKristi D Lynn, D Gomika Udugamasooriya, Christina L Roland, et al.
American Journal of Obstetrics and Gynecology|March 17, 2009
The impact of stress incontinence surgery on female sexual functionLinda Brubaker, Seine Chiang, Halina Zyczynski, et al.
Pageof 61

Showing results (221-230 of 604) with videos related to

Sort By:
Pageof 61
Drug and Alcohol Dependence|May 30, 2024
Longitudinal trajectories in recovery capital and associations with substance use among adult drug treatment court clientsKyler S Knapp, Jessica A Kulak, D Lynn Homish, et al.
Clinical and Translational Science|March 21, 2024
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteersD Lynn Kirkpatrick, Cari Evans, Linda A Pestano, et al.
Annals of Surgery|April 26, 2007
Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experienceSarah K Thompson, Amanda V Hayman, William H Ludlam, et al.
Psycho-Oncology|November 11, 2014
Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversyHeather Orom, Willie Underwood, D Lynn Homish, et al.
Psychological Services|February 15, 2019
Is deployment status the critical determinant of psychosocial problems among reserve/guard soldiers?Rachel A Hoopsick, D Lynn Homish, R Lorraine Collins, et al.
Plos One|November 6, 2009
Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancerChristina L Roland, Kristi D Lynn, Jason E Toombs, et al.
Molecular Cancer Therapeutics|January 19, 2008
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alphaMei Y Koh, Taly Spivak-Kroizman, Sara Venturini, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|January 12, 2008
Patterns and predictors of early hospital readmission in patients with congestive heart failureMarco Hallerbach, Amanda Francoeur, Sherry C Pomerantz, et al.
BMC Cancer|August 3, 2010
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancerKristi D Lynn, D Gomika Udugamasooriya, Christina L Roland, et al.
American Journal of Obstetrics and Gynecology|March 17, 2009
The impact of stress incontinence surgery on female sexual functionLinda Brubaker, Seine Chiang, Halina Zyczynski, et al.
Pageof 61